모시는글 프로그램 초록접수 사전등록 발표자 안내 수상자 안내 행사장안내 숙박안내 홈

일반연제 발표 유의사항

일반연제 발표자는 반드시 발표 슬라이드(파워포인트)를 사전에 제출하셔야 발표가 가능합니다.
슬라이드를 기한 내에 제출하지 않을 경우에는 발표불가능으로 간주합니다.
발표 슬라이드수는 15매 이내로 1장 당 10줄 이내로 제작하시는 것을 권장하며, 지정된 발표시간(7분 발표-3분 질의응답) 을 정확히 지켜주시기 바랍니다.

1. 파일 제출마감일 : 9월 17일 (목)
2. 파일 형태 : 파워포인트
3. 제출 방법 : ppt1@ksog.org


구연 - 전체   /    모체태아의학   /    부인종양학   /    생식내분비학   /    일반부인과학

[ 구연 - 부인종양학 ]

시간 번호 성명 소속 제목
좌장 : 김영태(연세의대)
13:00~13:40 GO1 정용욱 연세의대 Robot-assisted staging using three robotic arms for endometrial cancer: Comparison to laparoscopy and laparotomy at a single institution
GO2 신소진 계명의대 Regulatory Role of Osteopontin in Malignant Transformation of Endometrial Cancer
GO3 동서연 경희의대 Association of the hSRBC gene polymorphism with endometrial cancer
GO4 정근오 경북의대 Role of FDG PET in detecting myometrial invasion in patients with clinical stage I endometrial cancer
좌장 : 배덕수(성균관의대)
13:40~14:20 GO5 남주현 울산의대 The integration of aggressive surgical procedures to achieve optimal cytoreduction improves the survival of patients with FIGO stage IIIC-IV epithelial ovarian cancer
GO6 백지흠 연세의대 Utility of HE4 and CA125 as multiple serum tumor markers for the prediction of ovarian cancer
GO7 조한별 연세의대 Gene and protein expression profiling of newly established ovarian cancer cell lines: Identification of TOM40 and NP for ovarian cancer diagnosis and therapy
GO8 이희준 서울의대 Oxaliplatin, Leucovorin and 5-fluorouracil (FOLFOX-4) in Refractory Epithelial Ovarian Cancer: A Single Institutional Experience, 2002-2009
좌장 : 김승철(이화의대)
14:20~15:00 GO9 이신화 울산의대 Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix; a retrospective matched case-control study
GO10 유승철 아주의대 A validation study of new risk grouping criteria for tailoring postoperative adjuvant treatment in stage IB cervical cancer patients without high-risk factors: Rethinking the use of the GOG criteria
GO11 김윤환 서울의대 Prognostic Significance of VEGF Polymorphisms in Early Cervical Cancer
GO12 이수윤 이화의대 Genetic polymorphism of ataxia telangiectasia mutated and cervical neoplasia risk in Korean women.
좌장 : 박진완(단국의대)
15:00~15:40 GO13 전영은 연세의대 Identification of STIP-1 as a Diagnostic and Therapeutic Biomarker Candidate for Ovarian Cancer by two-dimensional DITA (differential gel electrophoresis analysis of immunoprecipitated tumor antigens)
GO14 김기형 부산의대 The Antitumor activity and Molecular mechanism of novel isoflavone derivative NV-128 in Epithelial ovarian cancer cells
GO15 조동휴 전북의대 Awareness of human papillomavirus among public health officials
GO16 조정아 성균관의대 Tumor-derived exosomes can induce differentiation of mesenchymal stem cells into tumor-associated myofibroblastic cells
좌장 : 최호선(전남의대)
15:40~16:20 GO17 이홍주 한양의대 Comparison of Mathematical Models to Detect Malignant pelvic masses in the preoperative evaluation
GO18 이성하 가톨릭의대 A clinicopathologic study in 1,042 patients with invasive cervical cancer: 10 years experience at the Department of Obstetrics and Gynecology of Kangnam St. Mary’s hospital
GO19 윤석근 관동의대 Evaluation of prognostic factors and clinical outcomes in uterine sarcoma
GO20 송재윤 고려의대 Body Mass Index change during Chemotherapy and prognosis in advanced ovarian cancer
좌장 : 노흥태(충남의대)
16:20~17:00 GO21 이유미 차의대 Comparison of results of treatment of patients with GTN referred to a trophoblastic disease center after failure of treatment elsewhere and primarily treated at trophoblastic disease center
GO22 오민정 전남의대 Significance of Human Papillomavirus Genotyping with High-grade Cervical Intraepithelial Neoplasia Treated by a Loop Electrosurgical Excision Procedure
GO23 김기동 원자력병원 Risk factors for central failure in patients with locally advanced cervical cancer
GO24 송은섭 인하의대 Clinical Analysis of Patients with of LSIL